Karen Weinstock
Psychiatric/Mental Health · Coral Springs, FLNPI 1952908352
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 355 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 355 payments — averaging $35.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Johnson & Johnson$1K
- Neurocrine Biosciences, Inc.$1K
- AbbVie$1K
- Axsome Therapeutics, Inc.$1K
- plus $4K from 14 others
What the payments were for
- Food & beverage$12,59899%
- Education$1581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 85 | $2,369 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 46 | $1,758 |
| Johnson & Johnson | 35 | $1,409 |
| Neurocrine Biosciences, Inc. | 31 | $1,242 |
| AbbVie | 39 | $1,058 |
| Axsome Therapeutics, Inc. | 16 | $1,030 |
| Vanda Pharmaceuticals Inc. | 39 | $1,010 |
| Alkermes, Inc. | 22 | $905 |
| Otsuka America Pharmaceutical, Inc. | 18 | $904 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $196 |
| Collegium Pharmaceutical, Inc. | 2 | $149 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $124 |
| Almatica Pharma LLC | 6 | $124 |
| Janssen Scientific Affairs, LLC | 1 | $110 |
| Corium, LLC | 3 | $78 |
| Sunovion Pharmaceuticals Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $45 |
| Indivior Inc. | 2 | $43 |
| Neos Therapeutics, LP | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,424
- ARISTADA$973
- Austedo XR$922
- CAPLYTA$734
- Auvelity$691
- INVEGA SUSTENNA$682
- INGREZZA$471
- Fanapt$375
- REXULTI$368
- UZEDY$357
- ARISTADA INITIO$243
- VRAYLAR$239
- ABILIFY MAINTENA$125
- QELBREE$125
- JORNAY PM$125
- SUNOSI$124
- COBENFY$124
- AUSTEDO$119
- SPRAVATO$117
How this compares
$12,757 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 13 | $279 |
| Benztropine Mesylate | 16 | $246 |
| Doxepin Hcl | 14 | $199 |
| Buspirone Hcl | 13 | $124 |
| Risperidone | 12 | $105 |
| Trazodone Hcl | 12 | $64 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Coral Springs
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
- Carolann BrooksCelebration$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.